Microfluidic platforms for discovery and detection of molecular biomarkers

Microfluidics and Nanofluidics

Volumn 16, Issue 5, 2014, Pages 941-963

  Hung, Lien Yu ^a   Wu, Hui Wen ^a   Hsieh, Kuangwen ^a   Lee, Gwo Bin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Detection of biomarkers; Discovery of biomarkers; Microfluidics; Molecular biomarker

Indexed keywords

BIOMOLECULES; FLUIDIC DEVICES; MICROFLUIDICS; NUCLEIC ACIDS; PUMPS;

BIO-MARKER DISCOVERY; MICRO-FLUIDIC DEVICES; MICROFLUIDIC PLATFORMS; MICROFLUIDIC-BASED; MINIATURE SYSTEMS; MOLECULAR BIOMARKER; MULTIPLEXED DETECTION; NUCLEIC ACID APTAMERS;

BIOMARKERS;

EID: 84899914378     PISSN: 16134982     EISSN: 16134990     Source Type: Journal    
DOI: 10.1007/s10404-014-1354-6     Document Type: Article

References (179)

1. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422(6928):198-207
2. Ahn JY, Jo M, Dua P, Lee DK, Kim S (2011) A sol-gel-based microfluidics system enhances the efficiency of RNA aptamer selection. Oligonucleotides 21(2):93-100
3. Alley WR, Madera M, Mechref Y, Novotny MV (2010) Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem 82(12):5095-5106
4. Alom J, Galard R, Catalan R, Castellanos JM, Schwartz S, Tolosa E (1990) Cerebrospinal fluid neuropeptide y in Alzheimer's disease. Eur Neurol 30(4):207-210
5. Armenta JM, Dawoud AA, Lazar IM (2009) Microfluidic chips for protein differential expression profiling. Electrophoresis 30(7):1145-1156
6. Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL, Grp BDW (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89-95
7. Barroso I, Luan J, Middelberg RPS, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1(1):41-55
8. Beebe DJ, Mensing GA, Walker GM (2002) Physics and applications of microfluidics in biology. Annu Rev Biomed Eng 4:261-286
9. Belgrader P, Tanner SC, Regan JF, Koehler R, Hindson BJ, Brown AS (2013) Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue. Clin Chem 59(6):991-994
10. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95(20):11891-11896
11. Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, Dhir R, DiSaia P, Gabra H, Glenn P, Godwin AK, Gross J, Hartmann L, Huang M, Huntsman DG, Iacocca M, Imielinski M, Kalloger S, Karlan BY, Levine DA, Mills GB, Morrison C, Mutch D, Olvera N, Orsulic S, Park K, Petrelli N, Rabeno B, Rader JS, Sikic BI, Smith-McCune K, Sood AK, Bowtell D, Penny R, Testa JR, Chang K, Dinh HH, Drummond JA, Fowler G, Gunaratne P, Hawes AC, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Santibanez J, Reid JG, Trevino LR, Wu YQ, Wang M, Muzny DM, Wheeler DA, Gibbs RA, Getz G, Lawrence MS, Cibulskis K, Sivachenko AY, Sougnez C, Voet D, Wilkinson J, Bloom T, Ardlie K, Fennell T, Baldwin J, Gabriel S, Lander ES, Ding L, Fulton RS, Koboldt DC, McLellan MD, Wylie T, Walker J, O'Laughlin M, Dooling DJ, Fulton L, Abbott R, Dees ND, Zhang Q, Kandoth C, Wendl M, Schierding W, Shen D, Harris CC, Schmidt H, Kalicki J, Delehaunty KD, Fronick CC, Demeter R, Cook L, Wallis JW, Lin L, Magrini VJ, Hodges JS, Eldred JM, Smith SM, Pohl CS, Vandin F, Raphael BJ, Weinstock GM, Mardis R, Wilson RK, Meyerson M, Winckler W, Verhaak RGW, Carter SL, Mermel CH, Saksena G, Nguyen H, Onofrio RC, Hubbard D, Gupta S, Crenshaw A, Ramos AH, Chin L, Protopopov A, Zhang J, Kim TM, Perna I, Xiao Y, Zhang H, Ren G, Sathiamoorthy N, Park RW, Lee E, Park PJ, Kucherlapati R, Absher DM, Waite L, Sherlock G, Brooks JD, Li JZ, Xu J, Myers RM, Laird PW, Cope L, Herman JG, Shen H, Weisenberger DJ, Noushmehr H, Pan F, Triche T Jr, Berman BP, Van den Berg DJ, Buckley J, Baylin SB, Spellman PT, Purdom E, Neuvial P, Bengtsson H, Jakkula LR, Durinck S, Han J, Dorton S, Marr H, Choi YG, Wang V, Wang NJ, Ngai J, Conboy JG, Parvin B, Feiler HS, Speed TP, Gray JW, Socci ND, Liang Y, Taylor BS, Schultz N, Borsu L, Lash AE, Brennan C, Viale A, Sander C, Ladanyi M, Hoadley KA, Meng S, Du Y, Shi Y, Li L, Turman YJ, Zang D, Helms EB, Balu S, Zhou X, Wu J, Topal MD, Hayes DN, Perou CM, Zhang J, Wu CJ, Shukla S, Sivachenko A, Jing R, Liu Y, Noble M, Carter H, Kim D, Karchin R, Korkola JE, Heiser LM, Cho RJ, Hu Z, Cerami E, Olshen A, Reva B, Antipin Y, Shen R, Mankoo P, Sheridan R, Ciriello G, Chang WK, Bernanke JA, Haussler D, Benz CC, Stuart JM, Benz SC, Sanborn JZ, Vaske CJ, Zhu J, Szeto C, Scott GK, Yau C, Wilkerson MD, Zhang N, Akbani R, Baggerly KA, Yung WK, Weinstein JN, Shelton T, Grimm D, Hatfield M, Morris S, Yena P, Rhodes P, Sherman M, Paulauskis J, Millis S, Kahn A, Greene JM, Sfeir R, Jensen MA, Chen J, Whitmore J, Alonso S, Jordan J, Chu A, Zhang J, Barker A, Compton C, Eley G, Ferguson M, Fielding P, Gerhard DS, Myles R, Schaefer C, Shaw KRM, Vaught J, Vockley JB, Good PJ, Guyer MS, Ozenberger B, Peterson J, Thomson E (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609-615
12. Berezovski MV, Lechmann M, Musheev MU, Mak TW, Krylov SN (2008) Aptamer-facilitated biomarker discovery (AptaBiD). J Am Chem Soc 130(28):9137-9143
13. Bllaci L, Kjellstrom S, Eliasson L, Friend JR, Yeo LY, Nilsson S (2013) Fast surface acoustic wave-matrix-assisted laser desorption ionization mass spectrometry of cell response from islets of Langerhans. Anal Chem 85(5):2623-2629
14. Boja ES, Rodriguez H (2012) Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics 12(8):1093-1110
15. Cambien F, Tiret L (2007) Genetics of cardiovascular diseases - from single mutations to the whole genome. Circulation 116(15):1714-1724
16. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, Dekernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, Macfarlane MT, Southwick PC (1994) Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate-cancer - results of a multicenter clinical-trial of 6,630 men. J Urol 151(5):1283-1290
17. Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J (2010) Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother 10(6):925-942
18. Chaiet L, Wolf FJ (1964) The properties of streptavidin, a biotin-binding protein produced by streptomycetes. Arch Biochem Biophys 106:1-5
19. Chang CM, Chang WH, Wang CH, Wang JH, Mai JD, Lee GB (2013) Nucleic acid amplification using microfluidic systems. Lab Chip 13(7):1225-1242
20. Chen YH, Lin HI, Huang CJ, Shiesh SC, Lee GB (2012) An automatic microfluidic system that continuously performs the systematic evolution of ligands by exponential enrichment. Microfluid Nanofluid 13(6):929-939
21. Cho M, Xiao Y, Nie J, Stewart R, Csordas AT, Oh SS, Thomson JA, Soh HT (2010) Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci USA 107(35):15373-15378
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, Natl High Blood Pressure Educ P (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206-1252
23. Choi S, Goryll M, Sin LYM, Wong PK, Chae J (2011) Microfluidic-based biosensors toward point-of-care detection of nucleic acids and proteins. Microfluid Nanofluid 10(2):231-247
24. Churchill E, Budas G, Vallcntin A, Koyanag T, Mochly-Rosen D (2008) PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol 48:569-599
25. Clackson T, Hoogenboom HR, Griffiths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352(6336):624-628
26. Cung K, Slater RL, Cui Y, Manivannan S, Jones SE, Ahmad H, Nelson CM, Naik RR, McAlpine MC (2012) Rapid, multiplexed microfluidic phage display. Lab Chip 12(24):5281
27. de Wit M, Fijneman RJA, Verheul HMW, Meijer GA, Jimenez CR (2013) Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clin Biochem 46(6):466-479
28. Decressac M, Wright B, Tyers P, Gaillard A, Barker RA (2010) Neuropeptide y modifies the disease course in the R6/2 transgenic model of Huntington's disease. Exp Neurol 226(1):24-32
29. Doerr A (2013) Mass spectrometry-based targeted proteomics. Nat Methods 10(1):23
30. El Debs B, Utharala R, Balyasnikova IV, Griffiths AD, Merten CA (2012) Functional single-cell hybridoma screening using droplet-based microfluidics. Proc Natl Acad Sci USA 109(29):11570-11575
31. Fan R, Vermesh O, Srivastava A, Yen BKH, Qin LD, Ahmad H, Kwong GA, Liu CC, Gould J, Hood L, Heath JR (2008) Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol 26(12):1373-1378
32. Fang XH, Tan WH (2010) Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 43(1):48-57
33. Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol Mech Dis 6:479-507
34. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48(1-2):155-171
35. Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18(11):1157-1161
36. Fortier MH, Bonneil E, Goodley P, Thibault P (2005) Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal Chem 77(6):1631-1640
37. Garcia CD, Henry CS (2004) Enhanced determination of glucose by microchip electrophoresis with pulsed amperometric detection. Anal Chim Acta 508(1):1-9
38. Garcia-Perez I, Vallejo M, Garcia A, Legido-Quigley C, Barbas C (2008) Metabolic fingerprinting with capillary electrophoresis. J Chromatogr A 1204(2):130-139
39. Gaster RS, Xu L, Han SJ, Wilson RJ, Hall DA, Osterfeld SJ, Yu H, Wang SX (2011) Quantification of protein interactions and solution transport using high-density GMR sensor arrays. Nat Nanotechnol 6(5):314-320
40. Ges IA, Baudenbacher F (2010) Enzyme-coated microelectrodes to monitor Lactate production in a nanoliter microfluidic cell culture device. Biosens Bioelectron 26(2):828-833
41. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52(2):568-572
42. Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, Onge PS, Kireeva I, Schmitt-Ulms G, Brown TJ, Murphy J, Rosen B, Shaw P, Jurisica I, Kislinger T (2008) A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J Proteome Res 7(1):339-351
43. Hamilton RG, MacGlashan DW, Saini SS (2010) IgE antibody-specific activity in human allergic disease. Immunol Res 47(1-3):273-284
44. Hanash SM, Baik CS, Kallioniemi O (2011) Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 8(3):142-150
45. Hardouin J, Joubert-Caron R, Caron M (2007) HPLC-chip-mass spectrometry for protein signature identifications. J Sep Sci 30(10):1482-1487
46. Hardy J, Selkoe DJ (2002) Medicine - the amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353-356
47. Herr AE, Hatch AV, Throckmorton DJ, Tran HM, Brennan JS, Giannobile WV, Singh AK (2007) Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci USA 104(13):5268-5273
48. Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM-Int J Med 96(11):793-807
49. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67(10):4827-4833
50. Hu Y, Gopal A, Lin K, Peng Y, Tasciotti E, Zhang XJ, Ferrari M (2011) Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip. Biomicrofluidics 5(1):013410
51. Huang CJ, Lin HI, Shiesh SC, Lee GB (2010) Integrated microfluidic system for rapid screening of crp aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX). Biosens Bioelectron 25(7):1761-1766
52. Huang CJ, Lin HI, Shiesh SC, Lee GB (2012) An integrated microfluidic system for rapid screening of alpha-fetoprotein-specific aptamers. Biosens Bioelectron 35(1):50-55
53. Hughes AJ, Lin RKC, Peehl DM, Herr AE (2012) Microfluidic integration for automated targeted proteomic assays. Proc Natl Acad Sci USA 109(16):5972-5977
54. Idle JR, Gonzalez FJ (2007) Metabolomics. Cell Metab 6(5):348-351
55. Irgon J, Huang CC, Zhang Y, Talantov D, Bhanot G, Szalma S (2010) Robust multi-tissue gene panel for cancer detection. BMC Cancer 10:319
56. Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, O'Connell CD (2005) Mitochondrial DNA as a cancer biomarker. J Mol Diagn 7(2):258-267
57. Jiang H, Weng XA, Li DQ (2011) Microfluidic whole-blood immunoassays. Microfluid Nanofluid 10(5):941-964
58. Jimeno A, Hidalgo M (2006) Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 5(4):787-796
59. Keller A, Leidinger P, Bauer A, ElSharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Muller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, Staehler C, Beier M, Scheffler M, Buchler MW, Wischhusen J, Haeusler SFM, Dietl J, Hofmann S, Lenhof HP, Schreiber S, Katus HA, Rottbauer W, Meder B, Hoheisel JD, Franke A, Meese E (2011) Toward the blood-borne miRNome of human diseases. Nat Methods 8(10):841-843
60. Kew M (1974) Alpha-fetoprotein in primary liver cancer and other diseases. Gut 15(10):814-821
61. Kijanka G, Murphy D (2009) Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteomics 72(6):936-944
62. Konopatskaya O, Poole AW (2010) Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci 31(1):8-14
63. Kotz KT, Xiao W, Miller-Graziano C, Qian W-J, Russom A, Warner EA, Moldawer LL, De A, Bankey PE, Petritis BO, Camp DG II, Rosenbach AE, Goverman J, Fagan SP, Brownstein BH, Irimia D, Xu W, Wilhelmy J, Mindrinos MN, Smith RD, Davis RW, Tompkins RG, Toner M, Inflammation Host Response (2010) Clinical microfluidics for neutrophil genomics and proteomics. Nat Med 16(9):1042-1047
64. Kraly JR, Holcomb RE, Guan Q, Henry CS (2009) Review: microfluidic applications in metabolomics and metabolic profiling. Anal Chim Acta 653(1):23-35
65. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2006) Botulinum toxin type a for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21(5):704-707
66. Lazar IM, Trisiripisal P, Sarvaiya HA (2006) Microfluidic liquid chromatography system for proteomic applications and biomarker screening. Anal Chem 78(15):5513-5524
67. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
68. Li JJ, LeRiche T, Tremblay TL, Wang C, Bonneil E, Harrison DJ, Thibault P (2002) Application of microfluidic devices to proteomics research - identification of trace-level protein digests and affinity capture of target peptides. Mol Cell Proteomics 1(2):157-168
69. Lim LS, Hu M, Huang MC, Cheong WC, Gan ATL, Looi XL, Leong SM, Koay ESC, Li MH (2012) Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells. Lab Chip 12(21):4388-4396
70. Lin CC, Wang JH, Wu HW, Lee GB (2010) Microfluidic immunoassays. J Lab Autom 15(3):253-274
71. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9(1):1-31
72. Liu Y, Adams JD, Turner K, Cochran FV, Gambhir SS, Soh HT (2009) Controlling the selection stringency of phage display using a microfluidic device. Lab Chip 9(8):1033-1036
73. Loos RJF, Bouchard C (2008) Fto: the first gene contributing to common forms of human obesity. Obes Rev 9(3):246-250
74. Lou X, Qian J, Xiao Y, Viel L, Gerdon AE, Lagally ET, Atzberger P, Tarasow TM, Heeger AJ, Soh HT (2009) Micromagnetic selection of aptamers in microfluidic channels. Proc Natl Acad Sci USA 106(9):2989-2994
75. Malo N, Hanley JA, Cerquozzi S, Pelletier J, Nadon R (2006) Statistical practice in high-throughput screening data analysis. Nat Biotechnol 24(2):167-175
76. Mandecki W, Chen YCJ, Grihalde N (1995) A mathematical-model for biopanning (affinity selection) using peptide libraries on filamentous phage. J Theor Biol 176(4):523-530
77. Mascini M, Palchetti I, Tombelli S (2012) Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. Angew Chem Int Ed 51(6):1316-1332
78. Meagher RJ, Hatch AV, Renzi RF, Singh AK (2008) An integrated microfluidic platform for sensitive and rapid detection of biological toxins. Lab Chip 8(12):2046-2053
79. Mendonsa SD, Bowser MT (2004) In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 76(18):5387-5392
80. Mendonsa SD, Bowser MT (2005) In vitro selection of aptamers with affinity for neuropeptide y using capillary electrophoresis. J Am Chem Soc 127(26):9382-9383
81. Merriman TR, Dalbeth N (2011) The genetic basis of hyperuricaemia and gout. Joint Bone Spine 78(1):35-40
82. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518
83. Mohammed MI, Desmulliez MPY (2011) Lab-on-a-chip based immunosensor principles and technologies for the detection of cardiac biomarkers: a review. Lab Chip 11(4):569-595
84. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stoeppler H, Simko J, Hilton JF, Carroll P, Blelloch R (2011) Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res 71(2):550-560
85. Mori Y, Olaru AV, Cheng YL, Agarwal R, Yang J, Luvsanjav D, Yu WN, Selaru FM, Hutfless S, Lazarev M, Kwon JH, Brant SR, Marohn MR, Hutcheon DF, Duncan MD, Goel A, Meltzer SJ (2011) Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer 18(4):465-478
86. Mosing RK, Bowser MT (2007) Microfluidic selection and applications of aptamers. J Sep Sci 30(10):1420-1426
87. Mosing RK, Mendonsa SD, Bowser MT (2005) Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 77(19):6107-6112
88. Murphy BM, He X, Dandy D, Henry CS (2008) Competitive immunoassays for simultaneous detection of metabolites and proteins using micromosaic patterning. Anal Chem 80(2):444-450
89. Nibbe RK, Koyutuerk M, Chance MR (2010) An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol 6(1):e1000639
90. Njoroge SK, Chen HW, Witek MA, Soper SA (2011) Integrated microfluidic systems for DNA analysis. Top Curr Chem 304:203-260
91. Oblak TD, Meyer JA, Spence DM (2009) A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes. Analyst 134(1):188-193
92. Ouattara DA, Prot J-M, Bunescu A, Dumas M-E, Elena-Herrmann B, Leclerc E, Brochot C (2012) Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3a cells. Mol BioSyst 8(7):1908-1920
93. Park SM, Ahn JY, Jo M, Lee DK, Lis JT, Craighead HG, Kim S (2009) Selection and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lab Chip 9(9):1206-1212
94. Patel R, Tsan A, Tam R, Desai R, Schoenbrunner N, Myers TW, Bauer K, Smith E, Raja R (2012) Mutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panel. PLoS ONE 7(12):e51153
95. Pedraza V, Gomez-Capilla JA, Escaramis G, Gomez C, Torne P, Rivera JM, Gil A, Araque P, Olea N, Estivill X, Esther Farez-Vidal M (2010) Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. Cancer 116(2):486-496
96. Pekin D, Skhiri Y, Baret J-C, Le Corre D, Mazutis L, Ben Salem C, Millot F, El Harrak A, Hutchison JB, Larson JW, Link DR, Laurent-Puig P, Griffiths AD, Taly V (2011) Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip 11(13):2156-2166
97. Pepe MS, Etzioni R, Feng ZD, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93(14):1054-1061
98. Pernagallo S, Ventimiglia G, Cavalluzzo C, Alessi E, Ilyine H, Bradley M, Diaz-Mochon JJ (2012) Novel biochip platform for nucleic acid analysis. Sensors 12(6):8100-8111
99. Pertega-Gomes N, Vizcaino JR, Gouveia C, Jeronimo C, Henrique RM, Lopes C, Baltazar F (2013) Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate 73(7):763-769
100. Petricoin EF, Ardekani AM, Hitt BA (2004) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 364(9434):582
101. Phillips KA, Van Bebber S, Issa AM (2006) Diagnostics and biomarker development: priming the pipeline. Nat Rev Drug Discov 5(6):463-469
102. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13(5):358-369
103. Prot JM, Leclerc E (2012) The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips. Ann Biomed Eng 40(6):1228-1243
104. Qian JR, Lou XH, Zhang YT, Xiao Y, Soh HT (2009) Generation of highly specific aptamers via micromagnetic selection. Anal Chem 81(13):5490-5495
105. Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP, Kunkel LM, Wagner KR (2012) Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci USA 109(40):16234-16239
106. Ramachandran N, Srivastava S, LaBaer J (2008) Applications of protein microarrays for biomarker discovery. Proteomics Clin App 2(10-11):1444-1459
107. Ramadan Q, Jafarpoorchekab H, Huang C, Silacci P, Carrara S, Koklue G, Ghaye J, Ramsden J, Ruffert C, Vergeres G, Gijs MAM (2013) Nutrichip: nutrition analysis meets microfluidics. Lab Chip 13(2):196-203
108. Rapi S, Bazzini C, Tozzetti C, Sbolci V, Modesti PA (2009) Point-of-care testing of cholesterol and triglycerides for epidemiologic studies; evaluation of the multicare-in system. Transl Res 153(2):71-76
109. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New Engl J Med 351(9):893-901
110. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13(11):1359-1362
111. Reginato AM, Mount DB, Yang I, Choi HK (2012) The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 8(10):610-621
112. Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis - a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc (JAMA) 285(19):2481-2485
113. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24(8):971-983
114. Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, Duffy DC (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28(6):595-599
115. Rizzi F, Belloni L, Crafa P, Lazzaretti M, Remondini D, Ferretti S, Cortellini P, Corti A, Bettuzzi S (2008) A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. PLoS ONE 3(10):e3617
116. 2+ activity oscillations in pancreatic islets. Proc Natl Acad Sci USA 101(35):12899-12903
117. Rodriguez S, Al-Ghamdi OA, Burrows K, Guthrie PAI, Lane JA, Davis M, Marsden G, Alharbi KK, Cox A, Hamdy FC, Neal DE, Donovan JL, Day INM (2013) Very low PSA concentrations and deletions of the KLK3 gene. Clin Chem 59(1):234-244
118. Rusling JF, Kumar CV, Gutkind JS, Patel V (2010) Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst 135(10):2496-2511
119. Sadygov RG, Cociorva D, Yates JR (2004) Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book. Nat Methods 1(3):195-202
120. Samii A, Nutt JG, Ransom BR (2004) Parkinson's disease. Lancet 363(9423):1783-1793
121. Savoia C, Schiffrin EL (2007) Reduction of C-reactive protein and the use of anti-hypertensives. Vasc Health Risk Manage 3(6):975-983
122. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene-expression patterns with a complementary-DNA microarray. Science 270(5235):467-470
123. Schmitz U, Versmold A, Kaufmann P, Frank HG (2000) Phage display: a molecular tool for the generation of antibodies - a review. Placenta 21:S106-S112
124. Sefah K, Shangguan D, Xiong XL, O'Donoghue MB, Tan WH (2010) Development of DNA aptamers using cell-SELEX. Nat Protoc 5(6):1169-1185
125. Shephard M, Peake M, Corso O, Shephard A, Mazzachi B, Spaeth B, Barbara J, Mathew T (2010) Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med 48(8):1113-1119
126. Shintu L, Baudoin R, Navratil V, Prot JM, Pontoizeau C, Defernez M, Blaise BJ, Domange C, Pery AR, Toulhoat P, Legallais C, Brochot C, Leclerc E, Dumas ME (2012) Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Anal Chem 84(4):1840-1848
127. Sidhu SS, Fairbrother WJ, Deshayes K (2003) Exploring protein-protein interactions with phage display. ChemBioChem 4(1):14-25
128. Sieben VJ, Marun CSD, Pilarski PM, Kaigala GV, Pilarski LM, Backhouse CJ (2007) FISH and chips: chromosomal analysis on microfluidic platforms. IET Nanobiotechnol 1(3):27-35
129. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, Mcguire WL (1987) Human-breast cancer - correlation of relapse and survival with amplification of the HER-2 neu oncogene. Science 235(4785):177-182
130. Smith GP (1985) Filamentous fusion phage - novel expression vectors that display cloned antigens on the virion surface. Science 228(4705):1315-1317
131. Snouber LC, Bunescu A, Naudot M, Legallais C, Brochot C, Dumas ME, Elena-Herrmann B, Leclerc E (2013) Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips. Toxicol Sci 132(1):8-20
132. Spurgeon SL, Jones RC, Ramakrishnan R (2008) High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS ONE 3(2):e1662
133. Srikumar N, Brown NJ, Hopkins PN, Jeunemaitre X, Hunt SC, Vaughan DE, Williams GH (2002) PAI-1 in human hypertension: relation to hypertensive groups. Am J Hypertens 15(8):683-690
134. Stern E, Vacic A, Rajan NK, Criscione JM, Park J, Ilic BR, Mooney DJ, Reed MA, Fahmy TM (2010) Label-free biomarker detection from whole blood. Nat Nanotechnol 5(2):138-142
135. Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24(4):381-403
136. Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV AIDS 5(6):463-466
137. Suzuki H, Matsugi Y (2005) Integrated microfluidic system for the simultaneous determination of ammonia, creatinine, and urea. Sensor Actuat B-Chem 108(1-2):700-707
138. Tai CH, Ho CL, Chen YL, Chen WL, Lee GB (2013) A novel integrated microfluidic platform to perform fluorescence in situ hybridization for chromosomal analysis. Microfluid Nanofluid. doi: 10.1007/s10404-10013-11190- 10400
139. Tang SSK, Gui GPH (2012) Biomarkers in the diagnosis of primary and recurrent breast cancer. Biomark Med 6(5):567-585
140. Tang J, Xie J, Shao N, Yan Y (2006) The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Electrophoresis 27(7):1303-1311
141. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 106(38):16157-16162
142. Thongboonkerd V, Songtawee N, Sritippayawan S (2007) Urinary proteome profiling using microfluidic technology on a chip. J Proteome Res 6(5):2011-2018
143. Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ-beta gene contributes to susceptibility and resistance to insulin-dependent diabetes-mellitus. Nature 329(6140):599-604
144. Tok J, Lai J, Leung T, Li SFY (2010) Selection of aptamers for signal transduction proteins by capillary electrophoresis. Electrophoresis 31(12):2055-2062
145. Toriello NM, Liu CN, Mathies RA (2006) Multichannel reverse transcription-polymerase chain reaction microdevice for rapid gene expression and biomarker analysis. Anal Chem 78(23):7997-8003
146. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment - RNA ligands to bacteriophage T4 DNA-polymerase. Science 249(4968):505-510
147. Ulrich H, Trujillo CA, Nery AA, Alves JM, Majumder P, Resende RR, Martins AH (2006) DNA and RNA aptamers: from tools for basic research towards therapeutic applications. Comb Chem High Throughput Screen 9(8):619-632
148. Vafiadis P, Ounissi-Benkalha H, Palumbo M, Grabs R, Rousseau M, Goodyer CG, Polychronakos C (2001) Class iii alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocr Metab 86(8):3705-3710
149. Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, Agirre X, Prosper F, Kiss T, Brousset P (2012a) Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia 26(9):2052-2060
150. Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, de Leval L, Gisselbrecht C, Gaulard P, Brousset P (2012b) Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood 120(19):3997-4005
151. van de Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999-2009
152. Van Roon-Mom WMC, Reid SJ, Faull RLM, Snell RG (2005) TATA-binding protein in neurodegenerative disease. Neuroscience 133(4):863-872
153. Vansteenkiste J, Dooms C, Mascaux C, Nackaerts K (2012) Screening and early detection of lung cancer. Ann Oncol 23:320-327
154. VerBerkmoes NC, Bundy JL, Hauser L, Asano KG, Razumovskaya J, Larimer F, Hettich RL, Stephenson JL (2002) Integrating "top-down" and "bottom-up" mass spectrometric approaches for proteomic analysis of shewanella oneidensis. J Proteome Res 1(3):239-252
155. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76(6):1560-1570
156. Vodnik M, Zager U, Strukelj B, Lunder M (2011) Phage display: selecting
157. Wallman L, Ekstrom S, Magnusson M, Bolmsjo G, Olsson M, Nilsson J, Marko-Varga G, Laurell T (2006) Robotic implementation of a microchip-based protein clean-up and enrichment system for MALDI-TOF MS readout. Meas Sci Technol 17(12):3147-3153
158. Walter K, Holcomb T, Januario T, Du P, Evangelista M, Kartha N, Iniguez L, Soriano R, Huw L, Stern H, Modrusan Z, Seshagiri S, Hampton GM, Amler LC, Bourgon R, Yauch RL, Shames DS (2012) DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer. Clin Cancer Res 18(8):2360-2373
159. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355(25):2631-2639
160. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10(1):57-63
161. Wang J, Liu Y, Teesalu T, Sugahara KN, Kotamrajua VR, Adams JD, Ferguson BS, Gong Q, Oh SS, Csordas AT, Cho M, Ruoslahti E, Xiao Y, Soh HT (2011) Selection of phage-displayed peptides on live adherent cells in microfluidic channels. Proc Natl Acad Sci USA 108(17):6909-6914
162. Wang XZ, Takebayashi SI, Bernardin E, Gilbert DM, Chella R, Guan JJ (2012) Microfluidic extraction and stretching of chromosomal DNA from single cell nuclei for DNA fluorescence in situ hybridization. Biomed Microdevices 14(3):443-451
163. Wang CH, Lai HC, Liou TML, Hsu KFH, Chou CYC, Lee GB (2013) A DNA methylation assay for detection of ovarian cancer cells using a HpaII/MspI digestion-based PCR assay in an integrated microfluidic system. Microfluid Nanofluid 15(5):575-585
164. Waring SC, Rosenberg RN (2008) Genome-wide association studies in Alzheimer disease. Arch Neurol 65(3):329-334
165. Washburn AL, Gunn LC, Bailey RC (2009) Label-free quantitation of a cancer biomarker in complex media using silicon photonic microring resonators. Anal Chem 81(22):9499-9506
166. Washburn AL, Luchansky MS, Bowman AL, Bailey RC (2010) Quantitative, label-free detection of five protein biomarkers using multiplexed arrays of silicon photonic microring resonators. Anal Chem 82(1):69-72
167. Weng CH, Hsieh IS, Hung LY, Lin HI, Shiesh SC, Chen YL, Lee GB (2013) An automatic microfluidic system for rapid screening of cancer stem-like cell-specific aptamers. Microfluid Nanofluid 14(3-4):753-765
168. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, Yan P, Schoenherr RM, Zhao L, Voytovich UJ, Kelly-Spratt KS, Krasnoselsky A, Gafken PR, Hogan JM, Jones LA, Wang P, Amon L, Chodosh LA, Nelson PS, McIntosh MW, Kemp CJ, Paulovich AG (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 29(7):625-634
169. Wilm M, Mann M (1996) Analytical properties of the nanoelectrospray ion source. Anal Chem 68(1):1-8
170. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12:433-455
171. Wu AHB, Smith A, Christenson RH, Murakami MM, Apple FS (2004) Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta 346(2):211-219
172. Wu RG, Yeung WSB, Fung YS (2011) 2-D t-ITP/CZE determination of clinical urinary proteins using a microfluidic-chip capillary electrophoresis device. Electrophoresis 32(23):3406-3414
173. Xie J, Miao YN, Shih J, Tai YC, Lee TD (2005) Microfluidic platform for liquid chromatography-tandem mass spectrometry analyses of complex peptide mixtures. Anal Chem 77(21):6947-6953
174. Yang Y, Iyer LK, Adelstein SJ, Kassis AI (2008) Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS ONE 3(11):e3661
175. Yu LM, Yu S, Mui EYY, McKelvie JC, Pham TPT, Yap YW, Wong WQ, Wu JW, Deng WQ, Orner BP (2009) Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site. Bioorg Med Chem 17(13):4825-4832
176. Yu D-C, Li Q-G, Ding X-W, Ding Y-T (2011a) Circulating microRNAs: potential biomarkers for cancer. Int J Mol Sci 12(3):2055-2063
177. Yu M, Wang QS, Patterson JE, Woolley AT (2011b) Multilayer polymer microchip capillary array electrophoresis devices with integrated on-chip labeling for high-throughput protein analysis. Anal Chem 83(9):3541-3547
178. Zhou XC, Mao JH, Ai JM, Deng YP, Roth MR, Pound C, Henegar J, Welti R, Bigler SA (2012) Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS ONE 7(11):e3661
179. Ziober BL, Mauk MG, Falls EM, Chen Z, Ziober AF, Bau HH (2008) Lab-on-a-chip for oral cancer screening and diagnosis. Head Neck-J Sci Spec 30(1):111-121